Etoperidone

Medical uses

Etoperidone was used or was intended for use as an antidepressant in the treatment of depression.

Etoperidone might be useful as a hallucinogen antidote or "trip killer" in blocking the effects of serotonergic psychedelics like psilocybin and lysergic acid diethylamide (LSD).

Pharmacology

Pharmacodynamics

Etoperidone is as an antagonist of several receptors in the following order of potency: 5-HT2A receptor (36 nM) α1-adrenergic receptor (38 nM) 5-HT1A receptor (85 nM) (may be a partial agonist) α2-adrenergic receptor (570 nM); it has only very weak or negligible affinity for blocking the following receptors: D2 receptor (2,300 nM) H1 receptor (3,100 nM) mACh receptors (35,000 nM). In addition to its receptor blockade, etoperidone also has weak affinity for the monoamine transporters as well: serotonin transporter (890 nM) norepinephrine transporter (20,000 nM) dopamine transporter (52,000 nM).

Pharmacokinetics

Etoperidone is metabolized in part to meta-chlorophenylpiperazine (mCPP), which likely accounts for its serotonergic effects.

Chemistry

Etoperidone is a phenylpiperazine and is chemically related to nefazodone and trazodone.

History

Etoperidone was discovered by scientists at Angelini, who also discovered trazodone. Its development names have included ST-1191 and McN-A-2673-11. The etoperidone was proposed in 1976 and recommended in 1977. The drug was given brand names in Spain (Centren (Esteve) and Depraser (Lepori)) and Italy (Staff (Sigma Tau)) and was also given the brand names Axiomin and Etonin, but it is not entirely clear if it was actually marketed; the Pharmaceutical Manufacturing Encyclopedia provides no dates for commercial introduction. According to Micromedex's Index Nominum: International Drug Directory, etoperidone was indeed previously marketed in Spain and Italy.

Society and culture

Generic names

Etoperidone is the generic name of the drug and its , while etoperidone hydrochloride is its .

Brand names

Etoperidone has been associated with the brand names Axiomin, Centren, Depraser, Etonin, and Staff.

Research

Etoperidone has been studied in dementia and found to be about as effective as thioridazine.

References

References

1. (2000). "Index Nominum 2000: International Drug Directory". Taylor & Francis.
2. William Andrew Publishing. (22 October 2013). "Pharmaceutical Manufacturing Encyclopedia". Elsevier.
3. (16 August 2012). "Bioactive Heterocyclic Compound Classes: Pharmaceuticals". John Wiley & Sons.
4. (23 August 2016). "Foundations of Mental Health Care - E-Book". Elsevier Health Sciences.
5. (January 2024). "Drug-drug interactions involving classic psychedelics: A systematic review". J Psychopharmacol.
6. "PDSP K_i Database". University of North Carolina at Chapel Hill and the United States National Institute of Mental Health.
7. (1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". Eur. J. Pharmacol..
8. (1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology.
9. (1993). "Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics". Biochem. Pharmacol..
10. (1985). "Active drug metabolites. An overview of their relevance in clinical pharmacokinetics". Clinical Pharmacokinetics.
11. (1992). "Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity". Psychopharmacology.
12. (2012). "Lead optimization for medicinal chemists: pharmacokinetic properties of functional groups and organic compounds". Wiley-VCH.
13. (1987). "Drug Discovery and Development". Springer Science & Business Media.
14. (1986). "Trazodone and the mental pain hypothesis of depression". Neuropsychobiology.
15. (1976). "Proposed INN List 36". Supplement to the WHO Chronicle.
16. (1977). "Recommended INN List 17". Supplement to the WHO Chronicle.
17. (2007). "Pharmaceutical Manufacturing Encyclopedia.". Elsevier.
18. (14 November 2014). "The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies". Springer.
19. (6 December 2012). "Concise Dictionary of Pharmacological Agents: Properties and Synonyms". Springer Science & Business Media.
20. (2001). "Thioridazine for dementia". The Cochrane Database of Systematic Reviews.